Wang Yao-Hua, Jiang Wen-Hao, Tu Yun-Hai, Zhou Guang-Ming, Wu Wen-Can, Yu Bo
Department of Orbital Diseases and Ophthalmic Tumor, Affiliated Eye Hospital of Nanchang University, Nanchang 330000, Jiangxi Province, China.
Eye Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China.
Int J Ophthalmol. 2022 Nov 18;15(11):1765-1771. doi: 10.18240/ijo.2022.11.06. eCollection 2022.
To evaluate the outcome of endoscopic dacryocystorhinostomy (En-DCR) with mucosal anastomosis in chronic dacryocystitis patients, with various categories of ethmoid sinuses.
Between July 2015 and September 2019, 1439 adult patients, representing 1623 affected eyes, presented with chronic dacryocystitis and were scheduled for En-DCR. The categories of ethmoid sinuses were preoperatively determined, using computed tomography-dacryocystography (CT-DCG), and were classified as category 1 (C1), category 2 (C2), and category 3 (C3). No sinuses anterior to the posterior lacrimal crest defined as C1. Sinuses found between the anterior edge of the lacrimal bone and the posterior lacrimal crest defined as C2. Sinuses found anterior to the lacrimal bone suture defined as C3. At the end of surgery, the dacryocyst and nasal mucosa were anastomosed in C1, and the dacryocyst mucosa and anterior ethmoid sinus were anastomosed in C2 and C3 ethmoid sinus patients. The surgical success rate and related complications, in patients with 3 categories of ethmoid cells, were monitored and documented.
Postoperative data was obtained for 179 C1 affected eyes, 878 C2 affected eyes, and 432 C3 affected eyes. The overall success rate of En-DCR was 93.0% (1385/1489). Additionally, the success rates were comparable among the different ethmoid categories at 12mo post operation. We demonstrated that the major reason for surgical failure was intranasal ostial closure, due to granulation or scar tissue.
En-DCR is a feasible and highly effective primary treatment for chronic dacryocystitis. To ensure surgical success, the surgery protocol must be designed in accordance with the category of ethmoid sinuses present in individual patient.
评估在患有不同类型筛窦的慢性泪囊炎患者中,采用黏膜吻合术的内镜下泪囊鼻腔造口术(En-DCR)的疗效。
2015年7月至2019年9月期间,1439例成年患者(代表1623只患眼)因慢性泪囊炎前来接受En-DCR手术。术前使用计算机断层扫描泪囊造影术(CT-DCG)确定筛窦类型,并分为1类(C1)、2类(C2)和3类(C3)。泪后嵴前方无鼻窦定义为C1。泪骨前缘与泪后嵴之间发现的鼻窦定义为C2。泪骨缝前方发现的鼻窦定义为C3。手术结束时,C1类患者将泪囊与鼻黏膜进行吻合,C2和C3类筛窦患者将泪囊黏膜与前筛窦进行吻合。对3类筛窦患者的手术成功率及相关并发症进行监测和记录。
获得了179只C1类患眼、878只C2类患眼和432只C3类患眼的术后数据。En-DCR的总体成功率为93.0%(1385/1489)。此外,术后12个月时,不同筛窦类型的成功率相当。我们发现手术失败的主要原因是鼻内开口因肉芽组织或瘢痕组织而闭合。
En-DCR是治疗慢性泪囊炎的一种可行且高效的主要方法。为确保手术成功,必须根据个体患者的筛窦类型设计手术方案。